Company
Endeavor BioMedicines
Disrupting Disease, Restoring Hope
Also known as ENDEAVOR BIOMEDICINES, INC.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- San Diego, United States
- Legal name
- ENDEAVOR BIOMEDICINES, INC.
- endeavorbiomedicines.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Endeavor BioMedicines is a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases.
Funding snapshot
- Total raised
- $222MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series C, $132M2024-04-24
Funding rounds
- Series C
- $132M2024-04-24, Announced
- Round, 2024
- $133M2024-04-22, SEC form D sold, 32 investors
- Round, 2022
- $89.1M2022-01-21, SEC form D sold, 16 investors
- Series A
- $62M2021-01-07, Announced
Products
- Web
- taladegib (ENV-101)
Loading relationship preview